Synthetic peptide corresponding to Human BCL7A (C terminal).
Séquence
C-MKLEASQQNSEEM
Hôte
Goat
Clonalité
Polyclonal
Isotype
IgG
Conjuguer
Unconjugated
Purification
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Concentration
100 µg at 0.5 mg/ml.
Forme du produit
Liquid
Formulation
Supplied in Tris Buffered Saline, pH 7.30, with 0.02% Sodium Azide and 0.5% BSA.
Stockage
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
Synonymes
B cell CLL/lymphoma 7, B cell CLL/lymphoma 7 protein family member A, B cell CLL/lymphoma 7A, B-cell CLL/lymphoma 7 protein family member A, BCL 7, Bcl 7A, BCL7, BCL7A_HUMAN
Figure 1: Western Blot - Anti-BCL7A Antibody (A82781)
Anti-BCL7A Antibody (A82781) staining (1µg/ml) of Human Lymphnode lysate (RIPA buffer, 35µg total protein per lane). Primary incubated for 1 hour. Detected by western blot using chemiluminescence.
Produits alternatifs à Anti-BCL7A Anticorps (A82781)
